**************************************************************

NW Tech Capital Inc., (NWTT.PK) is pleased to disclose the Canadian merger candidate, Bermal Contracting Ltd.

Bermal Contracting Inc. company excavates high quality ledge stone, used for landscaping. The unique stone found in the BC quarry is very popular among developers and is often used for rock walls, fireplaces, ponds, patios, house exteriors, fire pits, flower beds, stairs and walkways. The company has a miner licence and plans to invest in the necessary mining equipment.

The black flagstone stone found in the quarry is a favorite among customers, and Bermal is the only quarry to produce this color in the region. This stone is often used in the terrain surrounding swimming pools, because it doesn’t contain rust and will not stain.

Bermal Contracting’s dark grey and light grey ledge stone differ from the traditional rust brown stone. Soft lines and smooth textures of the ledge stone reflect the rugged feel of the mountains.

This quarry also hosts a deposit of light cobalt blue rock. A very valuable rock, it is becoming very popular for decorative flair. The rock is often crushed and used in driveways, dry flower beds and as accent pieces. The excavation of this rock will be explored in the future, once the company becomes established, and is certain to expand the company’s market base.

NWTT is completing negotiations with Bermal Contracting, and discussions are underway about merger logistics. Details about a definitive merger will be released shortly.

In other news, as part of the pre-merger negotiations, NWTT will build and launch new website with merger candidate information, and will formulate logistical solutions to effectively communicate with shareholders and future clients.

Park-Ohio Holdings Corp. (NASDAQ: PKOH) is a publicly held company that, through prudent investment strategies and long-term customer relationships with the majority of Fortune 100 companies, has achieved the #1 or #2 market position in more than 80% of our businesses, The #1 or #2 market position in more than 80% of our businesses, average tenure of on-going service to Top 50 customers in excess of six years and stable financial position with strong cash flows.

Since its founding, Park-Ohio Holdings Corp. and its subsidiaries have provided the strategic services and products the world’s leading manufacturers need to better and more efficiently build their own products.

Operating in two primary business areas, Supply Chain Management Services and Diversified Manufacturing, ParkOhio provides Total Supply Management™ solutions and highly engineered manufactured products to over 100 industry markets, from 80 company-owned locations in 16 countries.

With a customer base consisting of many of the Global 2000 infrastructure and business/personal/household products companies, the opportunities for growth are increasing for ParkOhio every day.

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer ) . Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has received fifteen thousand dollars in cash from a third party (PenStox) for (15) days of advertising for NW Tech Capital, Inc. (NWTT.PK)

PALM SPRINGS, Calif., July 31 /PRNewswire/ — Kaiser Ventures LLC and Mine Reclamation, LLC announced today that the U.S. 9th Circuit Court of Appeals on July 30, 2010, denied multiple requests for further review of an adverse November 2009 three-judge panel decision concerning Kaiser’s completed land exchange with the U. S. Bureau of Land Management (”BLM”) for the Eagle Mountain landfill project.

In November 2009, a three-judge panel of the U.S. 9th Circuit Court of Appeals rejected most of the landfill project opponents’ arguments challenging Kaiser’s completed land exchange with the BLM, but two of the judges ultimately affirmed the U.S. District Court’s prior ruling that the land exchange was not properly approved by the administrative agency. The third judge on the panel issued a 50-page dissent which is very critical of the majority’s opinion. The dissent argued that Kaiser, Mine Reclamation and the BLM fully complied with applicable law and that the completed land exchange should remain in effect.

In December 2009 Mine Reclamation, Kaiser, Riverside County, the Voluntary Employment Benefits Association and the Coachella Valley Economic Partnership and the Los Angeles County Sanitation District filed separate briefs supporting further review of the decision by an en banc panel of judges from the U.S. 9th Circuit Court of Appeals. An en banc panel consists of a total of eleven judges. It was this request for an en banc review that was denied by the 9th Circuit on Friday.

Rick Stoddard, Kaiser’s Chief Executive Officer and Chairman of Mine Reclamation said, “We are disappointed that an en banc review was not granted by the U.S. 9th Circuit Court of Appeals but remain committed to the land exchange and the Eagle Mountain project.” He also expressed that Kaiser and Mine Reclamation would be evaluating options with regard to the landfill and the completed land exchange including the potential to address the issues raised by the U.S. 9th Circuit by seeking a review of the decision by the U.S. Supreme Court. The U.S. Supreme Court reverses more decisions issued by the U.S. 9th Circuit Court of Appeals than any other federal court circuit.

The positive impacts of the Eagle Mountain landfill go far beyond being an extremely sound environmental disposal site. Stoddard said, “The landfill will assist Kaiser in helping to maintain the medical benefits of thousands of employees and spouses of the former Kaiser Steel Corporation. Riverside County will receive millions in new revenue to fund public services. The entire region benefits from the hundreds of new, family wage jobs that will be created as well as the provision of tens of millions of dollars to fund the Coachella Valley multi-species habitat conservation plan and for environmental research in Joshua Tree National Park.”

The Eagle Mountain landfill project is located in the remote eastern Riverside County desert and is proposed to accept up to 20,000 tons of non-hazardous solid waste per day for 50 years.

Disclaimer:
The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of Crown Equity Holdings or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company mentioned or referred to in the article.

QUINCY, Mass., July 31 /CRWENewswire/ — The National Labor Relations Board has determined that Quincy Medical Center “bargained in good faith” in its recent negotiations with the Massachusetts Nursing Association and management’s decision to declare an impasse and implement its final proposals was lawful and proper.

The MNA filed an unfair labor practice complaint with the NLRB on April 1, 2010, following the declaration of an impasse after mediation and weeks of negotiation on a new contract. The complaint claimed the hospital had engaged in bad faith bargaining.

“We believed all along that our talks with the nurses union were conducted properly and fairly and, though we differed on some important issues, our aim was to reach an outcome to achieve needed economic relief,” said Victor Munger, Senior Vice President of Human Resources at QMC. “We now look forward to returning to the table and negotiate a new agreement as we have done with other bargaining units.”

In the last month, bargaining units for the Service Employees International Union and Mass. Laborers Local 367 ratified extended contracts that included voluntary and temporary wage adjustments that will give the hospital’s management flexibility and time to implement a financial recovery plan intended to shore up QMC’s finances.

In addition, QMC and Tufts Medical Center recently announced a clinical affiliation to support and expand QMC’s ability to offer high-quality clinical services to local patients, and enhance area residents’ access to advanced, tertiary-level care.

“These developments, along with the tremendous support we have received from our medical staff are humbling and improves our prospects for success and a bright future,” Munger added. “We hope this progress can continue on all fronts, including with support from the nurses who are and remain vital to institution.”

Quincy Medical Center is a 196-bed acute care community-teaching hospital, providing the highest quality, most personalized and comprehensive medical and surgical services to patients throughout the South Shore. A private, nonprofit hospital, QMC has played a vital role in the community since 1890, serving the needs of its diverse patient population without exception. QMC is an academic affiliate of Boston University School of Medicine, and is a leader in quality benchmarks both state and nationwide.

Disclaimer:
The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of Crown Equity Holdings or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company mentioned or referred to in the article.

LAS VEGAS, NV–(crwenewswire - 07/31/10) - Pro-Pointer, Inc. (PPII.PK), through its wholly owned subsidiary, Coenzyme-A Technologies, Inc., is pleased to announce its latest innovative proprietary formula the “PURE COENZYME-A.” “Our product duplicates the biological functions used by the human body in the creation of cellular energy,” stated Nickolaos Skoaras, PhD., President / CEO of Coenzyme-A Technologies, Inc. “Coenzyme-A is the most active metabolic enzyme in the human body and as the initiator of the human body’s primary energy cycle; this is the purest form of energy there is,” Skouras added. Coenzyme-A is energy pure and simple. Besides its indispensable energy work, Coenzyme-A initiates the synthesis of a wide variety of other essential substances. These include acetylcholine (the key neurotransmitter in the brain), the steroid hormones (produced in the adrenal glands) and the sex hormones. It supports immune function, including the repair of DNA and RNA, plus healing from physical injury. It facilitates the manufacture of important components of connective tissue necessary to joint health, particularly chondroitin sulfate and hyaluronic acid. Lastly, Coenzyme-A retards the development of lactic acid build up during aerobic exercise preventing sore and stiff muscles.

ABOUT COENZYME-A TECHNOLOGIES, INC. — Coenzyme-A Technologies, Inc. is an innovative company that has applied new technology to the formulation and manufacture of a series of proprietary products which address nutritional deficiencies that result from the stress of modern day living, chemical imbalances within the body, and the deleterious effects of aging. Coenzyme-A is the first nutraceutical manufacture and utilization of cellular Coenzyme-A (The Master Coenzyme). Coenzyme-A contains a specific set of substrates that are designed to assist the body in converting fats, carbohydrates and proteins into energy at the cellular level. See Company website — www.coenzyme-a.com.

Contact:

Please note, new contact information:
Pro-Pointer, Inc.
458 Coral Sea St.
Henderson, NV 89074
Phone 702-458-4111
Cell 702-591-7440

Disclaimer:
The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of Crown Equity Holdings or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company mentioned or referred to in the article.

**************************************************************

MusclePharm Corporation (OTCBB:MSLP), a fast-growing nutritional supplement company with a proprietary formulation used in eight performance products, is reporting an exclusive distribution contract with PSI Distribution, a leading supplement distributor in Australia and New Zealand.

The exclusive contract will be worth $2 million in annual sales, allowing MusclePharm to expand into the Australian market and continue to grow as an international brand.

Included in the exclusive agreement with PSI is a combined opening purchase order of $500,000 dollars in MusclePharm products, which will begin shipping out in August. From there, a minimum Purchase Order of $500,000 in MusclePharm products will be made by PSI every 90 days, allowing MusclePharm to cultivate awareness in an area that has exploded in Ultimate Fighting Championship (UFC) and Mixed Martial Arts popularity.

MusclePharm’s top management has extensive experience in the sports world and has harnessed this drive and focus into building a business to benefit its customers and help Fuel The Athlete Inside™. Headquartered in Denver, Colorado, the company is a fast-growing developer and manufacturer of safe, scientifically approved nutritional supplements that are free of banned substances and tested by athletes. They are designed to help athletes, bodybuilders, weightlifters and fitness enthusiasts improve their performance. Each and every MusclePharm product is the end result of an advanced six-stage research and testing protocol involving the expertise of top nutrition scientists.

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) and Eisai Inc. reported that results from the two-year BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management) trial was published in the July 15, 2010, issue of the New England Journal of Medicine. The data presented in the article show that lorcaserin used in conjunction with behavioral modification caused significantly greater weight loss and improved maintenance of weight loss compared to placebo. Lorcaserin also improved values for biomarkers that may be predictive of future cardiovascular events, including lipid levels, insulin resistance, levels of inflammatory markers and blood pressure.

Steven R. Smith, M.D., Scientific Director of the Florida Hospital Translational Research Institute for Metabolism and Diabetes, was the lead author of the article. Neil J. Weissman, M.D., President of MedStar Health Research Institute and Professor of Medicine, Georgetown University, oversaw the echocardiographic safety evaluations that were performed in the study. Drs. Smith and Weissman served as BLOOM’s co-principal investigators.

Lorcaserin is a new chemical entity that is believed to act as a selective serotonin 2C receptor agonist. The serotonin 2C receptor is expressed in the brain, including the hypothalamus, an area involved in the control of appetite and metabolism.

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, an important class of validated drug targets, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena’s most advanced drug candidate, lorcaserin, is intended for weight management and has completed a pivotal Phase 3 clinical trial program.

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer ) . Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has received twenty five thousand dollars in cash and twenty five thousand dollars in free trading stock from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB)